News About: Pharm. Industry
Industry to seek niche markets with new natural crude drugs.
The Korea pharmaceutical industry understood that the new natural crude drug would be the most ideal item to explore a way of their survivals as a niche market which could be compatible instead of confrontation with t...
Jinyang Pharm's anti-SARS therapy is spotlighted in Southeast markets
As the outbreak of severe acute respiratory syndrome is hitting the Southeast regions, Jinyang Pharm's combination therapy of ribavirin plus steroid preparations there has been popular in the treatment of SARS and hep...
Impotence drugs in hot combatting market stage.
The competitive phase of impotence drug markets has been surfaced after completing their underground detecting works each other.
Lilly Korea is now concentrating their efforts on Cialis by recruiting more sales st...
MSD Korea President Lee Seung-woo Korea named executive director in Asia zone
According to MSD Korea, the incumbent president Lee Seung-woo is said to assume the position of executive director who will be responsible for the total strategic program in Asia but it made no comment on who will suc...
Pharmaceutical makers' total technical export revenue hovers at $500 million
Domestic pharmaceutical firms' total technical export volume amounted to about $470 million as of the end of 2002, the Korea Drug Research Association said recently.
According to tallies by the association,...
Industry trying to overcome business slump with total healthcare.
The pharmaceutical industry realized that they could never make their sales increases nor escape from the current prevailing business slump unless so called total healthcare business with functional foods and cosmetic...
Cialis sales in Europe on the steep rise.Elli Lilly launched Cialis, a new anti-impotence drug, to the European market in Feb. this year with so favorable response that the already preoccupied markets with Viagra seeme...
|
Net profits during first quarter this year plunged.
Most of listed pharmaceutical companies reported net profit declines during the first quarter of this year.
According to the Yakup Press data, 20 listed drug companies sold 660.9 billion won of their sales during t...
KOSDAQ-listed pharmaceutical firms fared well in the first half
According to statistics compiled by Yakup Shinmoon, KOSDAQ-listed pharmaceutical firms whose fiscal year closes March 31st fared well in the first quarter of this year. Details:
Turnover of KOSDAQ-listed ph...
Daewoong Pharm sells one capsule package of comp. Ursa
In an attempt to cope with the inconvenience of customers and pharmacists, Daewoong Pharm said that it had already supplied to pharmacies diverse package forms of composite Ursa capsule (60 capsules, 10 capsules, and ...
